I really don't want to be a doctor

Chapter 216 Beibei's Transplant Warehouse Life
After this recruitment, the Shenzhou Biopharmaceutical Laboratory currently has a total of 12 people, including R&D personnel and logistics personnel, and it can be regarded as officially on the right track of R&D.

Now the laboratory is mainly divided into two experimental groups, the first is the "immune checkpoint inhibitor" group led by Zhu Xianqing, and the other is the "mesenchymal stem cell" experimental group conducted by Jeffrey alone.

As the big boss of the lab, Jing Xiaoran is in charge of the research and development direction of the lab. He doesn't go out and do the experiments himself; he just needs to grasp the whole research and development idea and remove the obstacles of the experiment for everyone in time.

After all, "idea" is the primary productivity of the laboratory!
In fact, Jing Xiaoran's experimental ability is not strong, at best it is similar to Wang Tuo, or even worse.Because in his previous life, he did not focus on basic experiments, but more on clinical work.

In the "Immune Checkpoint Inhibitors" experimental group, Zhu Xianqing led most of the people in the laboratory to conduct research on drug mechanisms.In fact, Jing Xiaoran has already given Zhu Xian the specific drug pathway, but what he needs now is to put Jing Xiaoran's ideas into experiments.

As long as the drug pathways of immune checkpoint inhibitors are divided into two categories, PD-1/PDL-1, and CTL4.

Jing Xiaoran checked the databases of major papers around the world. At present, the mainstream drug pathways are PD-1/PDL-1, while CTL4 is relatively unpopular, and few laboratories publish papers in this area.

"Xiao Ran, I read the review of immune check inhibitors you gave me." Zhu Xianqing took the time to find Jing Xiaoran who was in the laboratory to discuss the experiment, "Since CTL4 is unpopular now, I think those big foreign companies may not We pay too much attention to this drug pathway, why don’t we seek a breakthrough in this area, so that we don’t need to directly compete with foreign pharmaceutical companies for scientific research…”

Jing Xiaoran understands Zhu Xianqing's thoughts. In his opinion, the background of Shenzhou Laboratory is far inferior to that of Pfizer and other pharmaceutical companies; starting with CTL4 is not a way of thinking to save the country.

But Jing Xiaoran denied Zhu Xianqing's thinking.

"Mr. Zhu, although there are relatively few people who study CTL4, once it is developed, it may be of greater significance, but we will also face great risks. Why do pharmaceutical companies such as Pfizer abandon CTL4? Will this drug pathway itself Is there a problem?"

"Or, the effect of this kind of drug developed by relying on this mechanism pathway is not as good as that of PD-1/PDL-1?"

Jing Xiaoran put forward his own thoughts, or in other words, he spoke out the experience of his previous life in advance.

In the previous life, the reason why the CTL4 pathway was unpopular was that the research and development personnel had discovered that the preparation of CTL4 was difficult, and the effect of the finished drug was worse than that of PD-1/PDL-1.

Therefore, in the pattern of immune check inhibitors in the previous life, the drugs based on the mechanism of PD-1/PDL-1 are dominant.

"What you said makes sense, but I'm still a bit unwilling to give up the CTL4 pathway like this." Zhu Xianqing hesitated.

For scientific researchers, as long as there is a slight possibility, they will do their best.

Jing Xiaoran smiled and said, "Mr. Zhu, I didn't ask you to give up the CTL4 pathway."

"Then, what do you mean..." Zhu Xianqing looked at Jing Xiaoran with some puzzlement.

"There are not enough personnel in the laboratory now. Although Jeffrey's experimental group has only two people, if you split your experimental group into two and study PD-1/PDL-1 and CTL4 respectively, then everyone will not only be stressed. It’s too big, and the progress of the experiment will be much slower.” Jing Xiaoran carefully calculated the manpower distribution of the laboratory, although the laboratory has recruited a new batch of experimental dogs, but it is not enough.

"After the lab is fully staffed, we will allocate some people to work on CTL4. Teacher Zhu, what do you think?" Jing Xiaoran looked at Zhu Xianqing who was at the side.

"Okay." Zhu Xianqing nodded slightly.

There are just enough R&D personnel in Shenzhou Lab, unlike big pharmaceutical companies like Pfizer, which often have dozens or hundreds of R&D personnel.

On the other side, it was Jeffrey who was more miserable. He mainly carried out the experimental project of "mesenchymal stem cells"; but he was basically fighting alone. Apart from him, the only rookie Hong Sheng in this experimental group.

Jing Xiaoran mainly considered that the current priority is "immune check inhibitors" and it involves a scientific research competition; while the "mesenchymal stem cell" experimental project is not difficult and does not lack time, so he made these arrangements.

The reason why Hong Sheng went to the "Mesenchymal Stem Cell" experimental group was entirely of his own accord.

According to his thinking, he mainly wants to practice English and experiment basic operations with Jeffrey...

……

The scientific research of Shenzhou Biological Drug Laboratory is proceeding in an orderly manner, and Jing Xiaoran was officially discharged from the emergency department and transferred to the hematology department of Fancheng Central Hospital.

Before being discharged from the emergency department, Jing Xiaoran never met that "paraquat" girl again.

This may be a good thing, because if you don't see it, it means there is still hope.

After reporting to the hematology department, Jing Xiaoran was assigned to Zhang Hang's group.This is also what Zhang Hang and the blood science secretary requested, but he has been waiting for Jing Xiaoran's arrival.

"That little girl, Beibei, is still in the warehouse, and she will be out of the warehouse in about 20 days."

Zhang Hang introduced Lin Beibei's stem cell transplantation to Jing Xiaoran.

Lin Beibei has been in the warehouse for more than ten days, and everything is going well so far.

The transplant warehouse is fully enclosed, and the care of patients in the warehouse belongs to the first level.The nursing staff patrols the patient about every 15-30 minutes, and the patient is infused almost 24 hours after entering the warehouse.

Because the transplant warehouse is a sterile environment, Jing Xiaoran also went into the warehouse wearing an isolation suit to visit Beibei.

Lin Beibei's face was still a bit fleshy, but after more than ten days in the warehouse, her little girl has lost weight visibly to the naked eye, and the flesh on her face has disappeared, showing the shape of her face.

These are all due to some reactions after entering the warehouse for chemotherapy, such as diarrhea and vomiting, resulting in poor appetite. Therefore, each patient entering the warehouse will have a weight difference of about 5 kg before and after.

"Brother Jing, I really want to eat cake."

The first time she saw Jing Xiaoran, Lin Beibei blinked her big eyes, and said what she had been thinking for more than ten days.

The food in the transplant warehouse should be as light as possible to avoid greasy food, otherwise it will easily lead to indigestion.

It is a small problem outside, but it is a big problem in this sterile transplant warehouse.

"Beibei, when you recover from your illness and leave this transplant warehouse, you can eat as much cake as you want." Jing Xiaoran said to Lin Beibei with a smile.

Life in the transplant warehouse is extremely boring. Nurses only visit the shift occasionally, and children are extremely lively. It is not easy for them to stay in one place for a long time.

Fortunately, Lin Yitian prepared a lot of comic books for Beibei, and there is also a TV in the transplant warehouse for everyone to watch.

But even so, when Jing Xiaoran was about to leave the transplant warehouse, Lin Beibei was still a little bit reluctant.

(End of this chapter)